Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
15.40-0.48 (-3.02%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close15.88
Bid12.75 x 500
Ask17.50 x 200
Day's Range15.30 - 15.83
52wk Range7.35 - 16.17
1y Target EstN/A
Market Cap2.24B
P/E Ratio (ttm)-22.88
Avg Vol (3m)1,165,718
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire4 days ago

    Ironwood Closes $150 Million Debt Refinancing

    Ironwood Pharmaceuticals, Inc. today announced the closing of a $150 million debt refinancing. Ironwood will use the net proceeds from this transaction to redeem the remaining principal balance of its existing Linaclotide PhaRMA 11% Notes due 2024.

  • Benzinga8 days ago

    BTIG Raises Ironwood Pharmaceuticals Price Target Ahead Of New Drug Launch

    BTIG believes Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) provides more than 15 percent upside from the current levels, pointing out the pipeline opportunities. In the current month alone, the stock ...

  • Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : September 14, 2016
    Capital Cube16 days ago

    Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : September 14, 2016

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Ironwood Pharmaceuticals, Inc. a score of 44. Our analysis is based on comparing Ironwood Pharmaceuticals, Inc. with the following peers – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, SGYP-US, ... Read more (Read more...)